Followers | 212 |
Posts | 12973 |
Boards Moderated | 0 |
Alias Born | 04/15/2016 |
![](https://investorshub.advfn.com/uicon/561410.png?cb=1631543931)
Thursday, July 22, 2021 10:49:15 AM
Recent IPA News
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/29/2024 12:38:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/29/2024 12:35:02 PM
- ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024 • Business Wire • 07/29/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/24/2024 01:55:46 AM
- ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024 • Business Wire • 07/23/2024 11:30:00 PM
- ImmunoPrecise annonce un accord de financement avec Yorkville Advisors Global, LP d'un montant en capital global de 3,0 millions USD de débentures convertibles • Business Wire • 07/17/2024 12:22:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/17/2024 01:41:01 AM
- ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures • Business Wire • 07/17/2024 12:01:00 AM
- IPA présentera le 25 juillet 2024 ses résultats financiers et les faits saillants récents de ses activités pour le quatrième trimestre et l'exercice financier 2024 • Business Wire • 07/16/2024 11:26:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/15/2024 12:32:43 PM
- IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024 • Business Wire • 07/15/2024 12:31:00 PM
- ImmunoPrecise nomme Kristin Taylor au poste de directeur financier • Business Wire • 06/27/2024 10:27:00 PM
- ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer • Business Wire • 06/27/2024 12:01:00 PM
- BioStrand, filiale d’IPA, et PGxAI annoncent un accord de collaboration stratégique visant à développer à l’aide de LENSai™ un modèle d’IA d’avant-garde pour les recommandations pharmacogénomiques • Business Wire • 06/25/2024 11:55:00 PM
- IPA’s Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™ • Business Wire • 06/25/2024 11:02:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/12/2024 05:01:33 PM
- BioStrand, filiale d’ImmunoPrecise Antibodies Ltd., reçoit le prestigieux prix Impact 2024 pour sa technologie LENSai™ révolutionnaire • Business Wire • 06/12/2024 11:00:00 AM
- ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology • Business Wire • 06/12/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/10/2024 06:23:10 PM
- BioStrand, filiale d’ImmunoPrecise Antibodies, annonce la disponibilité commerciale immédiate de son logiciel révolutionnaire doté d’une interface personnalisable pour la découverte de médicaments optimisée par l’IA • Business Wire • 06/10/2024 03:34:00 PM
- BioStrand, ImmunoPrecise Antibodies’ Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery • Business Wire • 06/10/2024 11:15:00 AM
- La filiale d’IPA, BioStrand, annonce un LLM avancé pour les dossiers de santé électroniques • Business Wire • 06/04/2024 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/04/2024 08:11:55 PM
- IPA’s Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR) • Business Wire • 06/04/2024 11:00:00 AM
- InterSystems et BioStrand, filiale d’IPA, collaborent au lancement de l’intégration innovante de la recherche vectorielle et de LENSai dans les applications de soins de santé pilotées par l’IA • Business Wire • 03/28/2024 06:35:00 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM